364 related articles for article (PubMed ID: 29287594)
1. Comprehensive molecular biomarker identification in breast cancer brain metastases.
Schulten HJ; Bangash M; Karim S; Dallol A; Hussein D; Merdad A; Al-Thoubaity FK; Al-Maghrabi J; Jamal A; Al-Ghamdi F; Choudhry H; Baeesa SS; Chaudhary AG; Al-Qahtani MH
J Transl Med; 2017 Dec; 15(1):269. PubMed ID: 29287594
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of differentially expressed long noncoding RNAs, miRNAs and mRNAs in breast cancer brain metastasis.
An M; Zang X; Wang J; Kang J; Tan X; Fu B
Epigenomics; 2021 Jul; 13(14):1113-1128. PubMed ID: 34148372
[TBL] [Abstract][Full Text] [Related]
3. LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
Van Swearingen AED; Siegel MB; Deal AM; Sambade MJ; Hoyle A; Hayes DN; Jo H; Little P; Dees EC; Muss H; Jolly T; Zagar TM; Patel N; Miller CR; Parker JS; Smith JK; Fisher J; Shah N; Nabell L; Nanda R; Dillon P; Abramson V; Carey LA; Anders CK
Breast Cancer Res Treat; 2018 Oct; 171(3):637-648. PubMed ID: 29938395
[TBL] [Abstract][Full Text] [Related]
4. Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer.
Lee JY; Park K; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Hong M; Do IG; Ahn T; Lee SK; Bae SY; Kim SW; Lee JE; Nam SJ; Kim DH; Jung HH; Kim JY; Ahn JS; Im YH; Park YH
Oncotarget; 2015 Dec; 6(41):43731-42. PubMed ID: 26527317
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential genes related to breast cancer brain metastasis in breast cancer patients.
Zhang L; Wang L; Yang H; Li C; Fang C
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34541602
[TBL] [Abstract][Full Text] [Related]
6. A novel panel of differentially-expressed microRNAs in breast cancer brain metastasis may predict patient survival.
Giannoudis A; Clarke K; Zakaria R; Varešlija D; Farahani M; Rainbow L; Platt-Higgins A; Ruthven S; Brougham KA; Rudland PS; Jenkinson MD; Young LS; Falciani F; Palmieri C
Sci Rep; 2019 Dec; 9(1):18518. PubMed ID: 31811234
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases.
Wikman H; Sielaff-Frimpong B; Kropidlowski J; Witzel I; Milde-Langosch K; Sauter G; Westphal M; Lamszus K; Pantel K
PLoS One; 2012; 7(10):e47537. PubMed ID: 23118876
[TBL] [Abstract][Full Text] [Related]
8. Gene Expression Profiling of Breast Cancer Brain Metastasis.
Lee JY; Park K; Lee E; Ahn T; Jung HH; Lim SH; Hong M; Do IG; Cho EY; Kim DH; Kim JY; Ahn JS; Im YH; Park YH
Sci Rep; 2016 Jun; 6():28623. PubMed ID: 27340107
[TBL] [Abstract][Full Text] [Related]
9. SNORA71B promotes breast cancer cells across blood-brain barrier by inducing epithelial-mesenchymal transition.
Duan S; Luo X; Zeng H; Zhan X; Yuan C
Breast Cancer; 2020 Nov; 27(6):1072-1081. PubMed ID: 32458152
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of breast cancer CTCs associated with brain metastasis.
Boral D; Vishnoi M; Liu HN; Yin W; Sprouse ML; Scamardo A; Hong DS; Tan TZ; Thiery JP; Chang JC; Marchetti D
Nat Commun; 2017 Aug; 8(1):196. PubMed ID: 28775303
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs and Extracellular Vesicles as Distinctive Biomarkers of Precocious and Advanced Stages of Breast Cancer Brain Metastases Development.
Figueira I; Godinho-Pereira J; Galego S; Maia J; Haskó J; Molnár K; Malhó R; Costa-Silva B; Wilhelm I; Krizbai IA; Brito MA
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069135
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis.
Shen Q; Sahin AA; Hess KR; Suki D; Aldape KD; Sawaya R; Ibrahim NK
Oncologist; 2015 May; 20(5):466-73. PubMed ID: 25802405
[TBL] [Abstract][Full Text] [Related]
14. Clonality of circulating tumor cells in breast cancer brain metastasis patients.
Riebensahm C; Joosse SA; Mohme M; Hanssen A; Matschke J; Goy Y; Witzel I; Lamszus K; Kropidlowski J; Petersen C; Kolb-Kokocinski A; Sauer S; Borgmann K; Glatzel M; Müller V; Westphal M; Riethdorf S; Pantel K; Wikman H
Breast Cancer Res; 2019 Sep; 21(1):101. PubMed ID: 31481116
[TBL] [Abstract][Full Text] [Related]
15. A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity.
McMullin RP; Wittner BS; Yang C; Denton-Schneider BR; Hicks D; Singavarapu R; Moulis S; Lee J; Akbari MR; Narod SA; Aldape KD; Steeg PS; Ramaswamy S; Sgroi DC
Breast Cancer Res; 2014 Mar; 16(2):R25. PubMed ID: 24625110
[TBL] [Abstract][Full Text] [Related]
16. Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary tumors.
Thulin A; Andersson C; Werner Rönnerman E; De Lara S; Chamalidou C; Schoenfeld A; Kovács A; Fagman H; Enlund F; Linderholm BK
Sci Rep; 2021 Dec; 11(1):23548. PubMed ID: 34876602
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases.
Huang RSP; Haberberger J; McGregor K; Mata DA; Decker B; Hiemenz MC; Lechpammer M; Danziger N; Schiavone K; Creeden J; Graf RP; Strowd R; Lesser GJ; Razis ED; Bartsch R; Giannoudis A; Bhogal T; Lin NU; Pusztai L; Ross JS; Palmieri C; Ramkissoon SH
Oncologist; 2021 Oct; 26(10):835-844. PubMed ID: 34105210
[TBL] [Abstract][Full Text] [Related]
18. microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy.
Kanchan RK; Siddiqui JA; Mahapatra S; Batra SK; Nasser MW
Mol Cancer; 2020 Feb; 19(1):29. PubMed ID: 32059676
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of circulating miR 802-5p and miR 194-5p and upregulation of brain MEF2C along breast cancer brain metastasization.
Sereno M; Haskó J; Molnár K; Medina SJ; Reisz Z; Malhó R; Videira M; Tiszlavicz L; Booth SA; Wilhelm I; Krizbai IA; Brito MA
Mol Oncol; 2020 Mar; 14(3):520-538. PubMed ID: 31930767
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity in the expression of receptors in the human breast cancer metastasized to the brain.
Rao PS; Labhart M; Mayhew SL; Thirumala S; Rao US
Tumour Biol; 2014 Jul; 35(7):7267-73. PubMed ID: 24777335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
